Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
NR2E3 loss disrupts photoreceptor cell maturation and fate in human organoid models of retinal development
Nathaniel K. Mullin, … , Edwin M. Stone, Budd A. Tucker
Nathaniel K. Mullin, … , Edwin M. Stone, Budd A. Tucker
Published April 23, 2024
Citation Information: J Clin Invest. 2024;134(11):e173892. https://doi.org/10.1172/JCI173892.
View: Text | PDF
Research Article Development Ophthalmology

NR2E3 loss disrupts photoreceptor cell maturation and fate in human organoid models of retinal development

  • Text
  • PDF
Abstract

While dysfunction and death of light-detecting photoreceptor cells underlie most inherited retinal dystrophies, knowledge of the species-specific details of human rod and cone photoreceptor cell development remains limited. Here, we generated retinal organoids carrying retinal disease–causing variants in NR2E3, as well as isogenic and unrelated controls. Organoids were sampled using single-cell RNA sequencing (scRNA-Seq) across the developmental window encompassing photoreceptor specification, emergence, and maturation. Using scRNA-Seq data, we reconstruct the rod photoreceptor developmental lineage and identify a branch point unique to the disease state. We show that the rod-specific transcription factor NR2E3 is required for the proper expression of genes involved in phototransduction, including rhodopsin, which is absent in divergent rods. NR2E3-null rods additionally misexpress several cone-specific phototransduction genes. Using joint multimodal single-cell sequencing, we further identify putative regulatory sites where rod-specific factors act to steer photoreceptor cell development. Finally, we show that rod-committed photoreceptor cells form and persist throughout life in a patient with NR2E3-associated disease. Importantly, these findings are strikingly different from those observed in Nr2e3 rodent models. Together, these data provide a road map of human photoreceptor development and leverage patient induced pluripotent stem cells to define the specific roles of rod transcription factors in photoreceptor cell emergence and maturation in health and disease.

Authors

Nathaniel K. Mullin, Laura R. Bohrer, Andrew P. Voigt, Lola P. Lozano, Allison T. Wright, Vera L. Bonilha, Robert F. Mullins, Edwin M. Stone, Budd A. Tucker

×

Figure 5

NR2E3-null rods fail to activate expression of rhodopsin.

Options: View larger image (or click on image) Download as PowerPoint
NR2E3-null rods fail to activate expression of rhodopsin.
(A) Violin plo...
(A) Violin plots show expression of NRL, NR2E3, and RHO within rods from either NR2E3-null or isogenic control organoids (D120 and D160 combined from the multimodal sequencing experiment in Figure 2). NR2E3-null rods express the transcription factors NRL and NR2E3 at the transcript level but do not express RHO transcript. (B) ATAC coverage tracks for isogenic control organoids (D160 and D260 combined) are shown. Accessibility in regions around RHO is observed in the rod cluster. (C) ATAC coverage for the rod cluster is shown for NR2E3-null and isogenic control samples. Below coverage tracks, ATAC peaks are shown as black boxes. Lines connecting peaks to the transcriptional start site of RHO represent peak-to-gene linkages. Two peaks (P1 and P2) that are linked to RHO expression and accessible only in control rods are highlighted in red. (D) CRX and NRL ChIP-Seq tracks from adult human donor eye samples are shown aligned to the tracks in C. NR2E3-dependent peaks highlighted in C are bound by NRL in human retina. (E–G) At D160, RHO-expressing photoreceptors are observed in ND control (E) and isogenic control (G) organoids, but no RHO-expressing cells are seen in NR2E3-null organoids (F). (H–J) By D260, RHO expression increases in ND control (H) and isogenic control (J) organoids but is still absent from NR2E3-null organoids (I). Scale bars: 50 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts